Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INOVIO PHARMACEUTICALS, INC.

(INO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about INOVIO PHARMACEUTICALS, INC.
02/12SECTOR UPDATE : Health Care Stocks Climbing in Friday Trading
MT
02/12MIDDAY REPORT : Wall Street Mixed Midday, Set For Second Weekly Rise
MT
02/12INOVIO PHARMACEUTICALS : Gains 17% After Upbeat Oppenheimer Report
MT
02/12INOVIO PHARMACEUTICALS : Oppenheimer Starts Inovio Pharmaceuticals at Outperform With $35 ..
MT
02/10Inovio expects to begin late-stage COVID-19 vaccine study in second quarter (Jan. 4)
RE
02/01Thermo Fisher sees 2021 profit above estimates on COVID-testing boost
RE
01/25INOVIO PHARMACEUTICALS : Announces Closing of Public Offering of Common Stock and Full Exe..
PR
01/21AFTER HOURS WATCH LIST SCORECARD : Sonm, oncs, ino
MT
01/21INOVIO PHARMACEUTICALS : Prices $150.5 Million Public Offering
MT
01/20INOVIO PHARMACEUTICALS : Announces Pricing of Public Offering of Common Stock
PR
01/20MT NEWSWIRES AFTER HOURS WATCH LIST : Sonm, oncs, ino
MT
01/20INOVIO PHARMACEUTICALS : Unveils $150 Million Offering of Shares
MT
01/20STREET COLOR : Inovio Pharmaceuticals Announces $150M Sale of Stock; Shares Fall Post-Mark..
MT
01/20INOVIO PHARMACEUTICALS : Announces Proposed Public Offering of Common Stock
PR
01/06INOVIO PHARMACEUTICALS : Reports Positive Efficacy in Phase 2 Trial of VGX-3100 to Treat V..
MT
01/06INOVIO PHARMACEUTICALS : VGX-3100 Demonstrates Positive Phase 2 Efficacy In Treatment of P..
PR
01/06INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy in Treatment of Precancerous V..
CI
01/04INOVIO PHARMACEUTICALS : Partners With Advaccine to Commercialize COVID-19 DNA Vaccine Can..
MT
01/04INOVIO PHARMACEUTICALS : partners with Advaccine to commercialize COVID-19 vaccine in Chin..
RE
01/04INOVIO PHARMACEUTICALS : and Advaccine Announce Exclusive Partnership To Commercialize COV..
PR
01/04INOVIO and Advaccine Announce Exclusive Partnership To Commercialize COVID-19 DNA Vacci..
CI
2020Stocks End Higher Ahead of Christmas Holiday as Investors Await Possible Higher Pandemi..
MT
2020SECTOR UPDATE : Health Care Stocks Hang On For Modest Gains
MT
2020INOVIO PHARMACEUTICALS' : Early Stage US Study Shows Potential of COVID-19 Vaccine Candida..
MT
2020INOVIO PHARMACEUTICALS : Announces Publication of Phase 1 Data from its COVID-19 DNA Vacci..
PR
2020INOVIO Announces Publication of Phase 1 Data from its COVID-19 DNA Vaccine Candidate, I..
CI
2020INOVIO PHARMACEUTICALS : Wins $38 Million Grant to Develop Antibody Technologies to Fight ..
MT
2020INOVIO PHARMACEUTICALS : to Develop DNA-encoded Monoclonal Antibody (dMAb«) Candidates to ..
PR
2020INOVIO PHARMACEUTICALS : Begins Dosing in Trial of COVID-19 DNA Vaccine Candidate in China
MT
2020INOVIO PHARMACEUTICALS : and Advaccine Announce First Dosing of Subject in Phase 2 Clinica..
PR
2020INOVIO PHARMACEUTICALS : Reports Positive Efficacy Results From Phase 2 Trial of VGX-3100;..
MT
2020INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy in Treatment of Precancerous A..
CI
2020INOVIO PHARMACEUTICALS : Doses First Patient in Study of COVID-19 Vaccine Candidate; Share..
MT
2020INOVIO PHARMACEUTICALS : doses first volunteer as part of its COVID-19 vaccine mid-stage t..
RE
2020INOVIO PHARMACEUTICALS : doses first participant of COVID-19 vaccine mid-stage trial
RE
2020INOVIO PHARMACEUTICALS : Doses First Subject in Phase 2 Segment of its INNOVATE Phase 2/3 ..
PR
2020Inovio Pharmaceuticals, Inc. Doses First Subject in Phase 2 Segment of its INNOVATE Pha..
CI
2020Inovio signs COVID-19 vaccine manufacturing deal with Japan's Kaneka
RE
2020INOVIO PHARMACEUTICALS : Adds Kaneka Eurogentec to its COVID-19 Vaccine Candidate Manufact..
MT
2020INOVIO PHARMACEUTICALS : Expands Global Manufacturing Consortium For Its COVID-19 Vaccine ..
PR
2020EXPLAINER : When and how will COVID-19 vaccines become available?
RE
2020INOVIO PHARMACEUTICALS : Doses First Subject in DNA Medicine Trial for Rare Disease Recurr..
MT
2020INOVIO PHARMACEUTICALS : Announces Dosing of First Subject in Phase 1/2 Clinical Trial for..
PR
2020INOVIO Announces Dosing of First Subject in Phase 1/2 Clinical Trial for INO-3107, its ..
CI
2020INOVIO PHARMACEUTICALS' : Study Shows Potential of Combination Cancer Therapy Candidate
MT
2020INOVIO PHARMACEUTICALS : Presents Clinical Results of its DNA Medicines INO-5401 + INO-901..
PR
2020Inovio Presents Clinical Results of Its DNA Medicines INO-5401 + INO-9012 in Novel Comb..
CI
2020PFIZER, MODERNA COVID-19 VACCINES MA : U.S. official
RE
2020INOVIO PHARMACEUTICALS : Roth Capital Downgrades Inovio Pharmaceuticals Back to Sell From ..
MT
2020SECTOR UPDATE : Health Care Stocks Struggle Despite More Positive News for COVID-19 Vaccin..
MT
2020SECTOR UPDATE : Narrow Declines for Health Care Stocks
MT
2020SECTOR UPDATE : Health Care
MT
2020Stocks Extend Gains in Early US Trading as More Vaccine Anticipation Bolsters Sentiment
MT
2020INOVIO PHARMACEUTICALS : to Begin Phase 2 of COVID-19 Vaccine Candidate Trial; Shares Gain..
MT
2020INOVIO PHARMACEUTICALS : to begin mid-stage study of COVID-19 vaccine candidate
RE
2020INOVIO PHARMACEUTICALS : to begin mid-stage study of COVID-19 vaccine candidate
RE
2020INOVIO PHARMACEUTICALS : Announces Initiation of Phase 2 Segment of its Phase 2/3 Clinical..
PR
2020Inovio Pharmaceuticals, Inc. Announces Initiation of Phase 2 Segment of Its Phase 2/3 C..
CI
2020INSIDER TRENDS : Insider 90-Day Selling Trend Extended at Inovio Pharmaceutical
MT
2020SECTOR UPDATE : Health Care Stocks Advancing Into Tuesday Close
MT
2020INOVIO PHARMACEUTICALS : Shares Surge 28% on Swing to Profit
MT
2020INOVIO PHARMACEUTICALS : Roth Capital Upgrades Inovio Pharmaceuticals to Neutral From Sell..
MT
2020INOVIO PHARMACEUTICALS : RBC Capital Adjusts Inovio Pharmaceuticals PT to $11 From $12, Ma..
MT
2020Arcturus expects its COVID-19 vaccine to be ready by Q1 2021
RE
2020Geneos Therapeutics, Inc. announced that it expects to receive $11.999997 million in fu..
CI
2020GRAPHIC : Tracking the vaccine race
RE
2020INOVIO : 3Q Earnings Snapshot
AQ
2020INOVIO PHARMACEUTICALS : Swings to Q3 Profit with Net Income of $0.12 a Share, Including G..
MT
2020INOVIO PHARMACEUTICALS : Earnings Flash (INO) INOVIO PHARMACEUTICALS Reports Q3 Revenue $2..
MT
2020INOVIO PHARMACEUTICALS : Reports Third Quarter 2020 Financial Results
PR
2020Inovio Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter Ended Septe..
CI
2020CEPI to fund development of COVID-19 vaccine candidate by China's Clover
RE
2020INOVIO PHARMACEUTICALS : to Report Third Quarter 2020 Financial Results on November 9, 202..
PR
2020Inovio Pharmaceuticals, Inc. Announces Changes to Its Board
CI
2020Stock lenders wince as hedge funds lose their shorts
RE
Prev.1  2   3  4  5  6  7  8  9  10Next
Upcoming event on INOVIO PHARMACEUTICALS, INC.
Upcoming sector events